{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:38:15Z","timestamp":1761917895703,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100011421","name":"Sanofi, China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011421","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s12325-020-01265-6","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T07:04:00Z","timestamp":1583305440000},"page":"1675-1687","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and Safety of Basal Insulin-Based Treatment Versus Twice-Daily Premixed Insulin After Short-Term Intensive Insulin Therapy in Patients with Type 2 Diabetes Mellitus in China: Study Protocol for a Randomized Controlled Trial (BEYOND V)"],"prefix":"10.1007","volume":"37","clinical-trial-number":[{"clinical-trial-number":"nct03359837","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Jing","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binhua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingcheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,4]]},"reference":[{"key":"1265_CR1","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/dmrr.2826","volume":"32","author":"J Weng","year":"2016","unstructured":"Weng J. Evolution in the Chinese Diabetes Society standards of care for type 2 diabetes. Diabetes Metab Res Rev. 2016;32:440\u20131.","journal-title":"Diabetes Metab Res Rev."},{"key":"1265_CR2","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1001\/jama.2017.7596","volume":"317","author":"L Wang","year":"2017","unstructured":"Wang L, Gao P, Zhang M, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA. 2017;317:2515\u201323.","journal-title":"JAMA"},{"key":"1265_CR3","unstructured":"International Diabetes Federation. IDF Diabetes Atlas (8th edition). Brussels, Belgium, 2017. https:\/\/www.idf.org\/e-library\/welcome.html. Accessed 26 Feb 2019."},{"key":"1265_CR4","doi-asserted-by":"publisher","first-page":"e0159297","DOI":"10.1371\/journal.pone.0159297","volume":"11","author":"Y Huang","year":"2016","unstructured":"Huang Y, Vemer P, Zhu J, Postma MJ, Chen W. Economic burden in Chinese patients with diabetes mellitus using electronic insurance claims data. PLoS ONE. 2016;11:e0159297.","journal-title":"PLoS ONE"},{"key":"1265_CR5","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837\u201353.","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"1265_CR6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"WC Knowler","year":"2002","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle or metformin. N Engl J Med. 2002;346:393\u2013403.","journal-title":"N Engl J Med"},{"key":"1265_CR7","doi-asserted-by":"crossref","unstructured":"Vinik A. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy. Clin Ther. 2007;29 Spec No:1236\u201353.","DOI":"10.1016\/j.clinthera.2007.07.005"},{"key":"1265_CR8","doi-asserted-by":"crossref","unstructured":"Belfiglio M, De Berardis G, Franciosi M, et al. for the QuED Study Group\u2013quality of care and outcomes in type 2 diabetes. The relationship between physicians\u2019 self-reported target fasting blood glucose levels and metabolic control in type 2 diabetes. The QuED Study Group\u2013quality of care and outcomes in type 2 diabetes. Diabetes Care. 2001;24:423\u20139.","DOI":"10.2337\/diacare.24.3.423"},{"key":"1265_CR9","unstructured":"Chinese Diabetes Society. China guideline for type 2 diabetes (2017 edition). Chin J Diabetes Mellitus. 2018;10:4\u201367."},{"key":"1265_CR10","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/dmrr.2827","volume":"32","author":"J Weng","year":"2016","unstructured":"Weng J, Ji L, Jia W, et al. Standards of care for type 2 diabetes in China. Diabetes Metab Res Rev. 2016;32:442\u201358.","journal-title":"Diabetes Metab Res Rev."},{"key":"1265_CR11","doi-asserted-by":"crossref","unstructured":"Nathan DM, Roussell A, Godine JE. Glyburide or insulin for metabolic control in non-insulin-dependent diabetes mellitus. A randomized, double-blind study. Ann Intern Med. 1988;108:334\u201340.","DOI":"10.7326\/0003-4819-108-3-334"},{"key":"1265_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2337\/dc08-9025","volume":"32","author":"DM Nathan","year":"2009","unstructured":"Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32:193\u2013203.","journal-title":"Diabetes Care"},{"key":"1265_CR13","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/dom.12886","volume":"19","author":"L Ji","year":"2017","unstructured":"Ji L, Zhang P, Zhu D, et al. Observational Registry of Basal Insulin Treatment (ORBIT) in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic drugs: real-life use of basal insulin in China. Diabetes Obes Metab. 2017;19:822\u201330.","journal-title":"Diabetes Obes Metab"},{"issue":"9 Suppl","key":"1265_CR14","doi-asserted-by":"publisher","first-page":"S503","DOI":"10.1097\/01.CCM.0000278046.24345.C7","volume":"35","author":"JC Preiser","year":"2007","unstructured":"Preiser JC, Devos P. Clinical experience with tight glucose control by intensive insulin therapy. Crit Care Med. 2007;35(9 Suppl):S503\u20137.","journal-title":"Crit Care Med"},{"issue":"Suppl 3","key":"1265_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1463-1326.2012.01658.x","volume":"14","author":"R Retnakaran","year":"2012","unstructured":"Retnakaran R, Zinman B. Short-term intensified insulin treatment in type 2 diabetes: long-term effects on \u03b2-cell function. Diabetes Obes Metab. 2012;14(Suppl 3):161\u20136.","journal-title":"Diabetes Obes Metab"},{"key":"1265_CR16","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.2337\/diacare.25.7.1159","volume":"25","author":"SL Norris","year":"2002","unstructured":"Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care. 2002;25:1159\u201371.","journal-title":"Diabetes Care"},{"key":"1265_CR17","doi-asserted-by":"crossref","unstructured":"Deakin T, McShane CE, Cade JE, Williams RD. Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005;(2):CD003417.","DOI":"10.1002\/14651858.CD003417.pub2"},{"key":"1265_CR18","first-page":"4175","volume":"125","author":"XH Guo","year":"2012","unstructured":"Guo XH, Yuan L, Lou QQ, et al. A nationwide survey of diabetes education, self-management and glycemic control in patients with type 2 diabetes in China. Chin Med J. 2012;125:4175\u201380.","journal-title":"Chin Med J"},{"key":"1265_CR19","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/1753-0407.12100","volume":"6","author":"XH Guo","year":"2014","unstructured":"Guo XH, Ji LN, Lu JM, et al. Efficacy of structured education in patients with type 2 diabetes mellitus receiving insulin treatment. J Diabetes. 2014;6:290\u20137.","journal-title":"J Diabetes."},{"issue":"40","key":"1265_CR20","first-page":"40","volume":"2012","author":"EQ Wu","year":"1995","unstructured":"Wu EQ, Zhou S, Yu A, et al. Outcomes associated with post-discharge insulin continuity in US patients with type 2 diabetes mellitus initiating insulin in the hospital. Hosp Pract. 1995;2012(40):40\u20138.","journal-title":"Hosp Pract"},{"key":"1265_CR21","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.jdiacomp.2015.04.003","volume":"29","author":"P Aschner","year":"2015","unstructured":"Aschner P, Sethi B, Gomez-Peralta F, et al. Insulin glargine compared with premixed insulin for management of insulin-na\u00efve type 2 diabetes patients uncontrolled on oral antidiabetic drugs: the open-label, randomized GALAPAGOS study. J Diabetes Compl. 2015;29:838\u201345.","journal-title":"J Diabetes Compl"},{"key":"1265_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.diabet.2011.11.001","volume":"38","author":"AJ Scheen","year":"2012","unstructured":"Scheen AJ. DPP-4 inhibitors in the management of type 2 diabetes: a critical review of head-to-head trials. Diabetes Metab. 2012;38:89\u2013101.","journal-title":"Diabetes Metab"},{"key":"1265_CR23","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2147\/IJGM.S51665","volume":"6","author":"J Gerich","year":"2013","unstructured":"Gerich J. Pathogenesis and management of postprandial hyperglycemia: role of incretin-based therapies. Int J Gen Med. 2013;6:877\u201395.","journal-title":"Int J Gen Med."},{"key":"1265_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s13300-015-0105-3","volume":"6","author":"C Mathieu","year":"2015","unstructured":"Mathieu C, Shankar RR, Lorber D, et al. A randomized clinical trial to evaluate the efficacy and safety of co-administration of sitagliptin with intensively titrated insulin glargine. Diabetes Ther. 2015;6:127\u201342.","journal-title":"Diabetes Ther."},{"key":"1265_CR25","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/1753-0407.12436","volume":"9","author":"Y Cao","year":"2017","unstructured":"Cao Y, Gao F, Zhang Q, et al. Efficacy and safety of coadministration of sitagliptin with insulin glargine in type 2 diabetes. J Diabetes. 2017;9:502\u20139.","journal-title":"J Diabetes."},{"key":"1265_CR26","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1177\/0300060514529555","volume":"42","author":"Y Sun","year":"2014","unstructured":"Sun Y, Shao L, Niu X, et al. Clinical effectiveness of Novolin\u00ae 30R versus Lantus\u00ae combined with Glucobay\u00ae treatment in elderly patients with type 2 diabetes mellitus controlled by oral hypoglycaemic agents: a randomized study. J Int Med Res. 2014;42:993\u20131001.","journal-title":"J Int Med Res"},{"key":"1265_CR27","unstructured":"Li Y-B, Ma J-H, Mu Y-M. Clinical expert guidance for short-term insulin intensive therapy for type 2 diabetes. Drug Evaluation, 2017;14(9):5\u201312,26. http:\/\/www.wanfangdata.com.cn\/details\/detail.do?_type=perio&id=yppj201709001. Accessed Oct 2019."},{"key":"1265_CR28","unstructured":"EQ-5D-5L questionnaire. https:\/\/euroqol.org\/. Accessed 7 Feb 2020."},{"key":"1265_CR29","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1089\/dia.2015.0054","volume":"17","author":"L Ji","year":"2015","unstructured":"Ji L, Zhang P, Weng J, et al. Observational Registry of Basal Insulin Treatment (ORBIT) in patients with type 2 diabetes uncontrolled by oral hypoglycemic agents in China\u2014study design and baseline characteristics. Diabetes Technol Ther. 2015;17:735\u201344.","journal-title":"Diabetes Technol Ther."},{"key":"1265_CR30","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/S0140-6736(08)60762-X","volume":"371","author":"J Weng","year":"2008","unstructured":"Weng J, Li Y, Xu W, et al. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomized parallel-group trial. Lancet. 2008;371:1753\u201360.","journal-title":"Lancet"},{"key":"1265_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2147\/DMSO.S104752","volume":"9","author":"L Ji","year":"2016","unstructured":"Ji L, Min KW, Oliveira J, Lew T, Duan R. Comparison of efficacy and safety of two starting insulin regimens in non-Asian, Asian Indian, and East Asian patients with type 2 diabetes: a post hoc analysis of the PARADIGM study. Diabetes Metab Syndr Obes. 2016;9:243\u20139.","journal-title":"Diabetes Metab Syndr Obes."},{"key":"1265_CR32","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/dme.12671","volume":"32","author":"CM Stein","year":"2015","unstructured":"Stein CM, Kramer CK, Zinman B, Choi H, Opsteen C, Retnakaran R. Clinical predictors and time course of the improvement in \u03b2-cell function with short-term intensive insulin therapy in patients with type 2 diabetes. Diabet Med. 2015;32:645\u201352.","journal-title":"Diabet Med"},{"key":"1265_CR33","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.2337\/dc11-0442","volume":"34","author":"FB Hu","year":"2011","unstructured":"Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care. 2011;34:1249\u201357.","journal-title":"Diabetes Care"},{"key":"1265_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2165\/00003495-200666010-00003","volume":"66","author":"AJ Garber","year":"2006","unstructured":"Garber AJ. Premixed insulin analogues for the treatment of diabetes mellitus. Drugs. 2006;66:31\u201349.","journal-title":"Drugs."},{"key":"1265_CR35","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1161\/CIRCULATIONAHA.112.115923","volume":"126","author":"A Pan","year":"2012","unstructured":"Pan A, Malik VS, Hu FB. Exporting diabetes mellitus to Asia: the impact of Western-style fast food. Circulation. 2012;126:163\u20135.","journal-title":"Circulation"},{"key":"1265_CR36","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.diabet.2014.08.006","volume":"40","author":"M Hanefeld","year":"2014","unstructured":"Hanefeld M. Use of insulin in type 2 diabetes: what we learned from recent clinical trials on the benefits of early insulin initiation. Diabetes Metab. 2014;40:391\u20139.","journal-title":"Diabetes Metab."},{"key":"1265_CR37","doi-asserted-by":"crossref","unstructured":"Lovre D, Fonseca V. Benefits of timely basal insulin control in patients with type 2 diabetes. J Diabetes Complications. 2015;29:295\u2013301.","DOI":"10.1016\/j.jdiacomp.2014.11.018"},{"key":"1265_CR38","doi-asserted-by":"publisher","first-page":"e1369","DOI":"10.1136\/bmj.e1369","volume":"344","author":"T Karagiannis","year":"2012","unstructured":"Karagiannis T, Paschos P, Paletas K, Matthews DR, Tsapas A. Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis. BMJ. 2012;344:e1369.","journal-title":"BMJ"},{"key":"1265_CR39","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1464-5491.2007.02094.x","volume":"24","author":"UK Dashora","year":"2007","unstructured":"Dashora UK, Sibal L, Ashwell SG, Home PD. Insulin glargine in combination with nateglinide in people with type 2 diabetes: a randomized placebo-controlled trial. Diabet Med. 2007;24:344\u20139.","journal-title":"Diabet Med"},{"key":"1265_CR40","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.diabres.2011.01.022","volume":"92","author":"MK Kim","year":"2011","unstructured":"Kim MK, Suk JH, Kwon MJ, et al. Nateglinide and acarbose for postprandial glucose control after optimizing fasting glucose with insulin glargine in patients with type 2 diabetes. Diabetes Res Clin Pract. 2011;92:322\u20138.","journal-title":"Diabetes Res Clin Pract"},{"key":"1265_CR41","doi-asserted-by":"publisher","first-page":"E414","DOI":"10.25011\/cim.v37i6.22247","volume":"37","author":"R Retnakaran","year":"2014","unstructured":"Retnakaran R. Emerging strategies for the preservation of pancreatic beta-cell function in early type 2 diabetes. Clin Invest Med. 2014;37:E414\u201320.","journal-title":"Clin Invest Med"},{"key":"1265_CR42","unstructured":"ClinicalTrials.gov. Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Main Trial) (RESET-IT). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02192424. Accessed 7 Feb 2020."}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01265-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-020-01265-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01265-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T16:29:32Z","timestamp":1628612972000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-020-01265-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1265"],"URL":"https:\/\/doi.org\/10.1007\/s12325-020-01265-6","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"type":"print","value":"0741-238X"},{"type":"electronic","value":"1865-8652"}],"subject":[],"published":{"date-parts":[[2020,3,4]]},"assertion":[{"value":"19 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}